MIRA INFORM REPORT

 

 

Report Date :

14.05.2014

 

IDENTIFICATION DETAILS

 

Name :

CHINA MEHECO CORPORATION

 

 

Registered Office :

No. 18 Guangming Middle Street, Dongcheng District, Beijing 100061 PR

 

 

Country :

China

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

18.07.1983

 

 

Com. Reg. No.:

110000008319434

 

 

Legal Form :

One-Person Limited Liability Company

 

 

Line of Business :

Subject includes selling Type medical appliances, including ophthalmic instruments, orthopedic surgical (orthopedics) instruments, family planning instruments, injection and puncture instruments, medical electronic instruments, medical optical instruments and camera for endoscopy, medical ultrasonic instruments and related instruments, medical Opto-laser equipment and instruments, medical high performance medical devices and instruments, physiatry and convalescence devices, equipment used in traditional Chinese medicine, magnetic resonance devices, medical X-ray equipment and auxiliary equipment and parts, high-energy radiation devices, medical nuclide devices, clinical check analysis instruments, clinical diagnostic reagents, extracorporeal circulation and blood treatment devices, implanting materials and artificial internal organ, operating room, emergency room, doctor's office devices, hospital nursing equipment and appliances, medical cooling treatment, low temperature, refrigeration plant and devices, dental materials, general healthcare materials and bandages, suture materials and adhesive, medical polymeric materials and products, medical X-ray equipment special detecting instrument; : microsurgical operating instrument, earnose-throat instruments, dental instruments, urination intestine surgical operating instrument, obstetrics and gynecology department instrument, general diagnostic instrument, dental equipment, sterilization and disinfection devices; Wholesale (non-physical way) of pre-packaged foods; processing Chinese Herbal Medicine (only branch operations). Sales of automobile (excluding nine below passenger car); import and export of goods and technology, import and export agent; warehousing services; sells grains, beans, potatoes, fodder; rental equipment and mechanical equipment; leasing of medical devices and equipment ; cultivation of Chinese herbal medicines; acquisition of agricultural and livestock products ( excluding those without obtaining a special permit).

 

 

No. of Employees

450

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

China

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately  High Risk

C1

High Risk

 

C2

Very High Risk

 

D

 

CHINA - ECONOMIC OVERVIEW

 

Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world's largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, growth of the private sector, development of stock markets and a modern banking system, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors considered important to "economic security," explicitly looking to foster globally competitive industries. After keeping its currency tightly linked to the US dollar for years, in July 2005 China moved to an exchange rate system that references a basket of currencies. From mid 2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation and expanded the daily trading band within which the RMB is permitted to fluctuate. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2013 stood as the second-largest economy in the world after the US, having surpassed Japan in 2001. The dollar values of China's agricultural and industrial output each exceed those of the US; China is second to the US in the value of services it produces. Still, per capita income is below the world average. The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic consumption; (b) facilitating higher-wage job opportunities for the aspiring middle class, including rural migrants and increasing numbers of college graduates; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy's rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2011 more than 250 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development. Several factors are converging to slow China's growth, including debt overhang from its credit-fueled stimulus program, industrial overcapacity, inefficient allocation of capital by state-owned banks, and the slow recovery of China's trading partners. The government's 12th Five-Year Plan, adopted in March 2011 and reiterated at the Communist Party's "Third Plenum" meeting in November 2013, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent in the future on fixed investments, exports, and heavy industry. However, China has made only marginal progress toward these rebalancing goals. The new government of President XI Jinping has signaled a greater willingness to undertake reforms that focus on China's long-term economic health, including giving the market a more decisive role in allocating resources

Source : CIA

 

 

 


Company name and address

 

CHINA MEHECO CORPORATION

NO. 18 GUANGMING MIDDLE STREET, DONGCHENG DISTRICT

BEIJING 100061 PR CHINA

TEL: 86 (0) 10-67107630/67116688

FAX: 86 (0) 10-67114290

 

 

EXECUTIVE SUMMARY

 

Date of Registration         : JULY 18, 1983

REGISTRATION NO.                  : 110000008319434

LEGAL FORM                           : One-person Limited Liability Company

CHIEF EXECUTIVE                      : WANG HONGXIN (LEGAL REPRESENTATIVE)

REGISTERED CAPITAL             : CNY 300,000,000

staff                                      : 450

BUSINESS CATEGORY             : TRADING

Revenue                                : CNY 1,578,415,000 (AS OF DEC. 31, 2013)

EQUITIES                                 : CNY 426,943,000 (AS OF DEC. 31, 2013)

WEBSITE                                  : N/A

E-MAIL                                     : trade@meheco.com.cn

PAYMENT                                : AVERAGE

MARKET CONDITION                : COMPETITIVE

FINANCIAL CONDITION             : fairly stable

OPERATIONAL TREND             : fairly STEADY

GENERAL REPUTATION           : AVERAGE

EXCHANGE RATE                    : CNY 6.24 = USD 1

 

Adopted abbreviations (as follows)

SC - Subject Company (the company inquired by you)

N/A – Not available

CNY – China Yuan Ren Min Bi

 

 

OPERATIONAL TREND & GENERAL REPUTATION

 

This section aims at indicating the relative positions of SC in respect of its operational trend & general reputation

 

Operational Trend:-                                            General Reputation:-

Upward                                                             Excellent

Steady                                                              Good

Fairly Steady                                                     Fairly Good

Ordinary                                                            Average

Fair                                                                   Fair

Stagnant                                                           Detrimental

Downward                                                         Not known

Not known                                                         Not yet be determined

Not yet be determined

 

 

LEGAL STATUS & HISTORY

 

SC was established as one-person limited liabilities company of PRC with State Administration of Industry & Commerce (SAIC) under registration No.: 110000008319434.

 

SC’s Organization Code Certificate No.: 10168985-5

SC’s Tax No.: 110103101689855

 

SC’s registered capital: CNY 300,000,000

 

SC’s paid-in capital: CNY 300,000,000

 

Registration Change Record:-

 

Date

Change of Contents

Before the change

After the change

2004-6-30

Company Name

China Traditional Medicines & Health Products Imp. & Exp. Corp.

China Meheco Corporation

 

Registered Capital

CNY 90,000,000

CNY 300,000,000

Legal Form

State-owned enterprise

Limited liabilities company

Legal Representative

Zhang Benfu

 

Han Benyi

 

2004-12-30

Shareholder (s) (% of Shareholding)

China General Technology (Group) Holding, Ltd.

76.96%

CNTIC Trading Co., Ltd.

23.04%

China General Technology (Group) Holding, Ltd.

0%

China Medicine and Health Products Co., Ltd.

90%

2007-12-28

Shareholder (s)

CNTIC Trading Co., Ltd.

 

China Medicine and Health Products Co., Ltd.

 

2009-12-21

Legal Representative

Han Benyi

 

Zhang Benzhi

 

--

Legal representative

Zhang Benzhi

 

Wang Hongxin

 

Shareholder (s) (% of Shareholding)

China General Technology (Group) Holding, Ltd.

10%

China Medicine and Health Products Co., Ltd.

90%

China Meheco Co., Ltd.

100%

Legal Form

Limited Liabilities Company

One-Person Limited Liabilities Company

 

Current Co search indicates SC’s shareholders & chief executives are as follows:-

 

Name of Shareholder (s)

% of Shareholding

China Meheco Co., Ltd.

 

100

 

SC’s Chief Executives:-

 

Position

Name

Legal Representative and Chairman

Wang Hongxin

General Manager

Guo Hong

Supervisor

Ma Xiaodong

 

 

RECENT DEVELOPMENT

 

No recent development was found during our checks at present.

 

 


SHAREHOLDER CHART & BACKGROUND

 

Name                                                                                       % of Shareholding

 

China Meheco Co., Ltd.

                                                                                                            100

-----------------------------

China Meheco Co., Ltd. is a listed company in Shanghai Stock Exchange Market with the code of 600056.

 

Date of Registration: May 8, 1997

Registration No.: 110000011645011

Legal Representative: Zhang Benzh

Web: www.meheco.cn

 

 

MANAGEMENT

 

Wang Hongxin, Legal Representative and Chairman

-------------------------------------------------------------------------------

Ø  Gender: M

Ø  Age: 48

Ø  Qualification: University

Ø  Working experience (s):

 

At present, working in SC as legal representative and chairman, also working in China Meheco Co., Ltd. as deputy general manager

 

Guo Hong, General Manager

----------------------------------------------

Ø  Gender: F

Ø  Qualification: University

Ø  Working experience (s):

 

At present, working in SC as general manager

 

Supervisor

--------------

Ma Xiaodong

 

 

BUSINESS OPERATION

 

SC’s registered business scope includes selling Type medical appliances, including ophthalmic instruments, orthopedic surgical (orthopedics) instruments, family planning instruments, injection and puncture instruments, medical electronic instruments, medical optical instruments and camera for endoscopy, medical ultrasonic instruments and related instruments, medical Opto-laser equipment and instruments, medical high performance medical devices and instruments, physiatry and convalescence devices, equipment used in traditional Chinese medicine, magnetic resonance devices, medical X-ray equipment and auxiliary equipment and parts, high-energy radiation devices, medical nuclide devices, clinical check analysis instruments, clinical diagnostic reagents, extracorporeal circulation and blood treatment devices, implanting materials and artificial internal organ, operating room, emergency room, doctor's office devices, hospital nursing equipment and appliances, medical cooling treatment, low temperature, refrigeration plant and devices, dental materials, general healthcare materials and bandages, suture materials and adhesive, medical polymeric materials and products, medical X-ray equipment special detecting instrument; : microsurgical operating instrument, earnose-throat instruments, dental instruments, urination intestine surgical operating instrument, obstetrics and gynecology department instrument, general diagnostic instrument, dental equipment, sterilization and disinfection devices; Wholesale (non-physical way) of pre-packaged foods; processing Chinese Herbal Medicine (only branch operations). Sales of automobile (excluding nine below passenger car); import and export of goods and technology, import and export agent; warehousing services; sells grains, beans, potatoes, fodder; rental equipment and mechanical equipment; leasing of medical devices and equipment ; cultivation of Chinese herbal medicines; acquisition of agricultural and livestock products ( excluding those without obtaining a special permit).

 

SC is mainly engaged in trading of medical appliances.

 

Brand:

 

SC’s products mainly include: Botanical Medicines, Health Products, Pharmaceuticals & Chemical medicines, Medical Instruments and Medical Sundries.

 

SC sources its merchandises 50% from the overseas market and 50% from domestic market. SC sells 50% of its merchandises in domestic market, and 50% to overseas market.

 

The buying terms of SC include Check, T/T, L/C and Credit of 30-60 days. The payment terms of SC include Check, T/T, L/C and Credit of 30-60 days.

 

*Major Customers:

==============

Nl Stores Inc.

Singhal Agro Products

Agricola Y Cultivos Altamira SAS

 

Staff & Office:

--------------------------

SC is known to have approx. 450 staff at present.

 

SC rents an area as its operating office, but the detailed information is unknown.

 

 

RELATED COMPANY

 

SC is known to invest in the following companies:

 

n  China Meheco Herbs Import & Export Corporation

 

n  Meheco Medicines & Chemicals I/E Corporation

 

n  China Meheco MISD I/E. Corporation

 

n  China Medical Equipment and Technical Service Company Ltd.

 

n  China Meheco Int'l Trade Development Company Ltd.

 

 

PAYMENT

 

Overall payment appraisal:

( ) Excellent      ( ) Good      (X) Average      ( ) Fair      ( ) Poor      ( ) Not yet be determined

The appraisal serves as a reference to reveal SC's payments habits and ability to pay.  It is based on the 3 weighed factors: Trade payment experience (through current enquiry with SC's suppliers), our delinquent payment and our debt collection record concerning SC.

 

Trade payment experience: SC did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.

 

Delinquent payment record: None in our database.

 

Debt collection record: No overdue amount owed by SC was placed to us for collection within the last 6 years.

 

 

BANKING

 

Basic Bank:

 

Bank of China General Office

AC#: 00028708094001

 

 

 


FINANCIALS

 

Financial Summary

Unit: CNY’000

As of Dec. 31, 2012

As of Dec. 31, 2013

Long term investment

12,560

12,560

Total assets

2,515,763

2,500,389

 

-------------

-------------

Total liabilities

2,102,368

2,073,446

Equities

413,395

426,943

 

-------------

-------------

Revenue

1,215,791

1,578,415

Profit before tax

48,476

15,938

Less: profit tax

9,132

2,390

Profits

39,344

13,548

 

Important Ratios

=============

 

As of Dec. 31, 2012

As of Dec. 31, 2013

*Liabilities to assets

0.84

0.83

*Net profit margin (%)

3.24

0.86

*Return on total assets (%)

1.56

0.54

*Revenue / Total assets

0.48

0.63

 

 

FINANCIAL COMMENTS

 

PROFITABILITY: AVERAGE

l  The revenue of SC appears fairly good in its line.

l  SC’s net profit margin is average.

l  SC’s return on total assets is average.

 

LIQUIDITY: FAIR

l  SC’s revenue is in a fair level, comparing with the size of its total assets.

 

LEVERAGE: AVERAGE

l  The debt ratio of SC is average.

l  The risk for SC to go bankrupt is low.

 

Overall financial condition of the SC: Fairly Stable.

 

 

CONCLUSIONS

 

SC is considered large-sized in its line with fairly stable financial conditions.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.59.87

UK Pound

1

Rs.100.98

Euro

1

Rs.82.40

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

PDT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.